Take Action For The International Thalassaemia Day 2021
Νέα

Take Action For The International Thalassaemia Day 2021

INTERNATIONAL THALASSAEMIA DAY 2021 – 8 MAY  ”Addressing Health Inequalities Across the Global Thalassaemia Community” Each year, individuals around the globe band together for one day of pure and empowering…
Oxbryta Increased Haemoglobin And Reduced Haemolysis in Adults and Adolescents With SCD
Clinical News

Oxbryta Increased Haemoglobin And Reduced Haemolysis in Adults and Adolescents With SCD

Global Blood Therapeutics, Inc. announced The Lancet Haematology has published the complete analysis of 72-week data from the Phase 3 HOPE Study of Oxbryta® (voxelotor) tablets in patients with sickle cell disease…
Hemanext® Inc. Receives CE Mark Certification For Innovative Red Blood Cell (RBC) Processing & Storage System
Clinical News

Hemanext® Inc. Receives CE Mark Certification For Innovative Red Blood Cell (RBC) Processing & Storage System

Hemanext Inc. announced today it has received a CE Certificate of Conformity for the CE Mark for its Hemanext ONE Red Blood Cell (RBC) Processing and Storage System, allowing the…
LIVING WITH THALASSAEMIA: A STRUGGLE & MANAGEMENT by Pranab Mishra
Patients’ stories

LIVING WITH THALASSAEMIA: A STRUGGLE & MANAGEMENT by Pranab Mishra

Thalassaemia has affected my life from various aspects. I was diagnosed with this disorder at the age of two and thalassaemia has been a part of my life since then.…
The International Thalassaemia Day 2021 Official Page is Now Live!
Νέα

The International Thalassaemia Day 2021 Official Page is Now Live!

INTERNATIONAL THALASSAEMIA DAY 2021 – 8 MAY  ”Addressing Health Inequalities Across the Global Thalassaemia Community” Visit the International Thalassaemia Day page, now LIVE on TIF website, to find out why…
TIF Presents Its Newly Launched SCD Educational Course for Healthcare Professionals On 9 April
Νέα

TIF Presents Its Newly Launched SCD Educational Course for Healthcare Professionals On 9 April

TIF is delighted to announce the organisation of a Virtual Presentation Event of the ‘TIF Sickle Cell Disease Educational Course for Healthcare Professionals’ – an online course providing comprehensive information…
Blood Donors’ COVID-19 Antibodies: Do They Have A Positive Significance for Blood Recipients?
Νέα

Blood Donors’ COVID-19 Antibodies: Do They Have A Positive Significance for Blood Recipients?

According to recent data released by the American Red Cross, in the first week of March 2021 more than 20% of blood donations from unvaccinated people in the US had…
COMING UP: New TIF Webinar On ”COVID-19 Vaccinations & Patients With Haemoglobin Disorders”
Νέα

COMING UP: New TIF Webinar On ”COVID-19 Vaccinations & Patients With Haemoglobin Disorders”

TIF is delighted to inform you that a Special Webinar on ‘’COVID-19 Vaccinations & Patients with Haemoglobin Disorders’’ will take place on Wednesday, 31 March 2021, at 14:30-16:00 EEST/12:30-14:00 GMT.…
A Head-to-Head Comparison of BMT, Gene Therapy & Gene Editing Through A Brand New TIF Infographic
Νέα

A Head-to-Head Comparison of BMT, Gene Therapy & Gene Editing Through A Brand New TIF Infographic

The expansion of management options and therapies for patients with thalassaemia is nowadays a reality, thanks to the application of new, revolutionary scientific procedures. However, patients’ understanding on the distinct…
Potentially Curative Approaches for β-Thalassaemia (2021)
TIF Publications

Potentially Curative Approaches for β-Thalassaemia (2021)

A TIF-developed infographic providing a head-to-head comparison on the most essential aspects of BMT, Gene Therapy & Gene Editing as potentially curative procedures for patients with β-thalassaemia.
Back to top button